Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Neuronetics Inc
STIM | US
1.27
USD-0.02
-1.55%
STIM | US
Loading StockChartView...
About Neuronetics Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
12/03/2026
Close
1.27
Open
1.26
High
1.28
Low
1.23
Neuronetics Inc. a commercial stage medical technology company designs develops and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics Inc. was incorporated in 2001 and is headquartered in Malvern Pennsylvania.
View LessSTIM | US
Risk
116.9
Sharpe
-0.89
Luna's Score
27/100
Recommendation
Sell
Luna says (STIM | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
80.5%1 month
116.9%3 months
116.1%6 months
100.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.52
Debt to equity
3.23
Debt to assets
0.65
Ent. to EBITDA
-2.02
Ent. to rev.
0.68
PEG
-
Other Fundamentals
EBITDA
-24.65M
MarketCap
38.48M
MarketCap(USD)
38.48M
Div. yield
-
Op. margin
-51.71
Erngs. growth
-
Rev. growth
-6.60
Ret. on equity
-100.13
Short ratio
1.57
Short perc.
1.98
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.28
Range1M
0.96
Range3M
1.14
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.24
Price X volume
783.04K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.02 | 12.67 | Cheaper |
| Ent. to Revenue | 0.68 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 1.52 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 116.07 | 59.59 | Riskier |
| Debt to Equity | 3.23 | -14.36 | Expensive |
| Debt to Assets | 0.65 | 0.34 | Expensive |
| Market Cap | 38.48M | 13.71B | Emerging |
